Mark Zupancic | Karolinska Institutet

Publications
CV
Public outreach and news

Articles

Article: CLINICAL CANCER RESEARCH. 2024;30(13):2764-2771
Cell-Free Human Papillomavirus DNA Is a Sensitive Biomarker for Prognosis and for Early Detection of Relapse in Locally Advanced Cervical Cancer
Sivars L; Jylha C; Crona Guterstam Y; Zupancic M; Lindqvist B; Nordenskjold M; Tham E; Hellman K
Article: ANTICANCER RESEARCH. 2024;44(5):1863-1876
Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer Cell Lines Regardless of HPV Status
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Article: ORAL ONCOLOGY. 2024;151:106749
Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival
Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylha C; Marklund L; Nasman A; Sivars L; Dalianis T
Article: CANCERS. 2023;15(7):1954
High Levels of FGF11 Correlate with Poor Survival in Patients with Human Papillomavirus (HPV)-Positive Oropharyngeal Squamous Cell Carcinoma
de Flon CH; Haeggblom L; Holzhauser S; Kostopoulou ON; Zupancic M; Dalianis T; Munck-Wikland E; Marklund L; Nasman A
Article: CANCERS. 2023;15(5):1499
Adenoid Cystic Carcinoma (AdCC): A Clinical Survey of a Large Patient Cohort
Zupancic M; Nasman A; Berglund A; Dalianis T; Friesland S
Article: CANCERS. 2022;15(1):93
Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited
Byskata K; Lukoseviciute M; Tuti F; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Article: VIRUSES. 2022;14(7):1372
Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors
Kostopoulou ON; Zupancic M; Pont M; Papin E; Lukoseviciute M; Mikelarena BA; Holzhauser S; Dalianis T
Article: VIRUSES. 2022;14(5):1040
Analysis of Human Papillomavirus (HPV) and Polyomaviruses (HPyVs) in Adenoid Cystic Carcinoma (AdCC) of the Head and Neck Region Reveals Three HPV-Positive Cases with Adenoid Cystic-like Features
Zupancic M; Holzhauser S; Cheng L; Ramqvist T; Du J; Friesland S; Nasman A; Dalianis T
Article: VIRUSES. 2021;13(9):1861
Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma-An Even Broader Tumor Entity?
Zupancic M; Nasman A
Article: CANCERS. 2021;13(11):2553
Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status
Wendt M; Hammarstedt-Nordenvall L; Zupancic M; Friesland S; Landin D; Munck-Wikland E; Dalianis T; Nasman A; Marklund L
Article: ONCOLOGY LETTERS. 2021;21(4):277
Psoriasin expression is associated with survival in patients with human papillomavirus-positive base of tongue squamous cell carcinoma
Zupancic M; Haeggblom L; Landin D; Marklund L; Dalianis T; Nasman A
Article: SCIENTIFIC REPORTS. 2021;11(1):1782
Tumour inflammation signature and expression of S100A12 and HLA class I improve survival in HPV-negative hypopharyngeal cancer
Mints M; Landin D; Nasman A; Mirzaie L; Ursu RG; Zupancic M; Marklund L; Dalianis T; Munck-Wikland E; Ramqvist T
Article: ACTA OTO-LARYNGOLOGICA. 2021;141(1):89-94
The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer
Hammarstedt L; Holzhauser S; Zupancic M; Kapoulitsa F; Ursu RG; Ramqvist T; Haeggblom L; Nasman A; Dalianis T; Marklund L
Article: FRONTIERS IN ONCOLOGY. 2021;11:640490
Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations
Holzhauser S; Wild N; Zupancic M; Ursu RG; Bersani C; Nasman A; Kostopoulou ON; Dalianis T
Article: EUROPEAN JOURNAL OF CANCER. 2020;139:192-200
Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8-Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas
Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Nasman A

All other publications

Review: ANTICANCER RESEARCH. 2024;44(4):1325-1334
Adenoid Cystic Carcinoma, Clinical Presentation, Current Treatment and Approaches Towards Novel Therapies
Zupancic M; Naesman A; Friesland S; Dalianis T
Thesis / dissertation: 2023
Diagnostic and prognostic markers in primarily non-smoking related head and neck cancer
Zupancic, Mark
Other: CASE REPORTS IN ONCOLOGY. 2023;16(1):525-531
Transient Coma and Signs of Encephalopathy Related to 5-Fluorouracil and Carboplatin: A Case Report
Zupancic M; Farrajota Neves da Silva P; Kas Elyas K; Friesland S; Ellingsen Cederoe T; Gerling M
Review: VIRUSES. 2021;13(5):910
Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma
Nasman A; Holzhauser S; Kostopoulou ON; Zupancic M; Ahrlund-Richter A; Du J; Dalianis T

Employments

Affiliated to Research, Department of Oncology-Pathology, Karolinska Institutet, 2023-2026

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 2023

News from KI

Events from KI